Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant.
Botta C, Gigliotta E, Paiva B, Anselmo R, Santoro M, Otero PR, Carlisi M, Conticello C, Romano A, Solimando AG, Cerchione C, Vià MD, Bolli N, Correale P, Di Raimondo F, Gentile M, San Miguel J, Siragusa S. Botta C, et al. Among authors: carlisi m. Hematol Oncol. 2022 Dec;40(5):987-998. doi: 10.1002/hon.3041. Epub 2022 Jul 11. Hematol Oncol. 2022. PMID: 35794705 Free PMC article.
Cardio-oncology in multiple myeloma: is it time for a specific focus?
Mancuso S, Carlisi M, Sarocchi M, Napolitano M, Siragusa S. Mancuso S, et al. Among authors: carlisi m. Leuk Lymphoma. 2018 Jul;59(7):1764-1766. doi: 10.1080/10428194.2017.1393674. Epub 2017 Oct 31. Leuk Lymphoma. 2018. PMID: 29087234 No abstract available.
Lymphomas and thyroid: Bridging the gap.
Mancuso S, Carlisi M, Napolitano M, Siragusa S. Mancuso S, et al. Among authors: carlisi m. Hematol Oncol. 2018 Feb 27. doi: 10.1002/hon.2504. Online ahead of print. Hematol Oncol. 2018. PMID: 29484690 Review.
Immunosenescence and lymphomagenesis.
Mancuso S, Carlisi M, Santoro M, Napolitano M, Raso S, Siragusa S. Mancuso S, et al. Among authors: carlisi m. Immun Ageing. 2018 Sep 21;15:22. doi: 10.1186/s12979-018-0130-y. eCollection 2018. Immun Ageing. 2018. PMID: 30258468 Free PMC article. Review.
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network.
Conticello C, Romano A, Del Fabro V, Martino EA, Calafiore V, Sapienza G, Leotta V, Parisi MS, Markovic U, Garibaldi B, Leotta S, Cotzia E, Innao V, Mannina D, Neri S, Musso M, Scalone R, Cangialosi C, Acquaviva F, Cardinale G, Merenda A, Maugeri C, Uccello G, Poidomani M, Longo G, Carlisi M, Tibullo D, Di Raimondo F. Conticello C, et al. Among authors: carlisi m. J Clin Med. 2019 Jun 19;8(6):877. doi: 10.3390/jcm8060877. J Clin Med. 2019. PMID: 31248142 Free PMC article.
37 results